跳至主要内容
临床试验/NCT03142061
NCT03142061已完成不适用

Prospective Evaluation of Clinical Efficacy and Symptom Control Using Electrochemotherapy for the Inoperable Advanced Vulva Carcinoma

University Hospital Tuebingen2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
2
主要终点
Symptom control

研究概览

简要总结

Electrochemotherapy (ECT) with Bleomycin in non-operable advanced vulva carcinoma

详细描述

Prospective evaluation of tumor response towards ECT by photo documentation. In addition prospective documentation of life quality after ECT treatment as well as evaluation of pain. .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • informed consent
  • age ≥ 55 years (postmenopausal)
  • histologically proved cutan accessible vulva carcinoma
  • a maximum of 5 lesions ≥1 - ≤ 5 cm diameter; a maximum thickness of 3 cm
  • applied electrochemotherapy with electroporation

排除标准

  • Non compliant patients
  • Patients with symptomatic or rapidly progredient metastasis outside of the vulva

结局指标

主要结局

Symptom control

时间窗: Baseline

exulceration, secretion

local tumor control

时间窗: Baseline

according to RECIST criteria

次要结局

  • Pain(Baseline, 3, 6 months)
  • Life quality(Baseline, 3, 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验